Daily non-political popular news in brief.

Timing is everything when using IL-7 to boost antiviral immunity

02-01-2008 · EurekAlert!

CD8+ T cells are an important component of the antiviral immune response. Much research effort is being invested in identifying new ways to boost antiviral immune responses in individuals with chronic viral infections. Although the use of the soluble factor IL-7 has proven attractive, new data indicate that the timing of IL-7 treatment is important in determining how effective it is at enhancing antiviral immunity.

Keywords: timing, everything, il-7, boost, antiviral, immunity

« Previous | Next »

Similar news on "Timing is everything when using IL-7 to boost antiviral immunity":

JCI online early table of contents: Feb. 1, 2008
02-01-2008 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Feb. 1, 2008, in the JCI, including: Timing is everything when using IL-7 to boost antiviral immunity; Precursor cells may provide clues to cardiac development; Ouch, Smad hurts! Smad7 may inhibit wound healing; Managing chronic pain; Genetic differences translated into functional diversity: New way to assess the importance of cross-reactive CD8+ T cells; and others.
Similar news · Read more »
Anthrax vaccine produces immunity with nanoparticles, not needles
08-15-2007 · EurekAlert!
A nasal vaccine made with emulsified soybean oil shows strong promise in initial animal studies. University of Michigan scientists say the result could be a better anthrax vaccine that requires no shots, is effective with only one or two immunizations, needs no refrigeration and could be used effectively after a bioterrorism attack to boost immune response in exposed people.
Similar news · Read more »
JCI table of contents: September 13, 2007
09-13-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, September 13, 2007, in the JCI, including: Understanding the Noxious cause of Lou Gehrig's disease; What makes a fungus virulent? It's lipase; TREM-1 has the guts to mediate inflammation; Timing is everything when treating viral infections; Two stimuli better than one at inducing mucus production; Breaking down the molecular pathway to a neuromuscular disease; and others.
Similar news · Read more »
Eltrombopag effective for hepatitis C patients with low blood-platelet counts
12-28-2007 · EurekAlert!
For patients with hepatitis C, having a low blood platelet count is a frequent complication associated with advanced disease. This problem is compounded by the fact that standard antiviral treatment for the disease can further reduce platelet numbers to dangerously low levels, effectively denying these patients the treatment they urgently need. Now, research published in the New England Journal of Medicine finds that a new drug, eltrombopag, appears to significantly boost platelet counts, opening the door to effective treatment.
Similar news · Read more »
Evolutionary battle scars' identify enhanced antiviral activity
01-24-2008 · EurekAlert!
Rapid evolution of a protein produced by an immunity gene is associated with increased antiviral activity in humans, a finding that suggests evolutionary biology and virology together can accelerate the discovery of viral-defense mechanisms, according to researchers at Fred Hutchinson Cancer Research Center in Seattle. These findings, published Jan. 25 in the open-access journal PLoS Genetics, present a striking example by which evolutionary studies can directly lead to biomedically important discoveries in the field of infectious diseases.
Similar news · Read more »
Genetic breakthrough supercharges immunity to flu and other viruses
02-13-2008 · EurekAlert!
Researchers at McGill University have discovered a way to boost an organism's natural anti-virus defenses, effectively making its cells immune to influenza and other viruses. Their results are to be published Feb. 13 in the journal Nature.
Similar news · Read more »
Carnegie Mellon study reveals that odor discrimination is linked to the timing at which neurons fire
11-07-2006 · EurekAlert!
Timing is everything. For a mouse trying to discriminate between the scent of a tasty treat and the scent of the neighborhood cat, timing could mean life or death. In a striking discovery, Carnegie Mellon University scientists have linked the timing of inhibitory neuron activity to the generation of odor-specific patterns in the brain's olfactory bulb, the area of the brain responsible for distinguishing odors.
Similar news · Read more »
New insights into vaccination for HIV
01-24-2008 · EurekAlert!
A group of Australian researchers at the Universities of Melbourne and New South Wales have developed new tools and paradigms to understand immune evasion from HIV. The study, published Friday, Jan. 25 in PLoS Pathogens, shows that both prior vaccination and timing influence the rates of immune escape, providing further insight into the effectiveness of T cell immunity to HIV.
Similar news · Read more »
T cell immunity enhanced by timing of interleukin-7 therapy
02-01-2008 · EurekAlert!
A team of scientists from the University of Wisconsin-Madison has found that the timing of interleuin-7 therapy is critical for increasing the number of killer cells that zero in on and destroy virus-infected cells.
Similar news · Read more »
JCI table of contents: Nov. 8, 2007
11-08-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Nov. 8, 2007, in the JCI, including: Atrogin breaks down the side effects of statins; Sex, sugar, and metabolic disease; New mouse strain teaches us about GPCRs; Too many red blood cells spoil the mouse; Two faces for TNF-alpha in antiviral and antitumor immunity; Making mice breathe easy: a role for IL-1 in lung damage; and others.
Similar news · Read more »